Biomarker-guided CAR-T therapy (SELECT-SLE target selection)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biomarker-guided CAR-T therapy (SELECT-SLE target selection), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus [Phase 1, Phase 2]